Cellulosic Biotherapeutics LLC is categorized under Research and Development Laboratories in Philadelphia, PA and active since 2009.
Cellulosic Biotherapeutics LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Steven Nicoll at the company’s single location by writing to 3160 Chestnut St, Philadelphia, Pennsylvania PA 19104 or by phoning (215) 573-8196. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cellulosic Biotherapeutics LLC |
| Contact Person: | Steven Nicoll |
| Address: | 3160 Chestnut St, Philadelphia, Pennsylvania 19104 |
| Phone Number: | (215) 573-8196 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Cellulosic Biotherapeutics LLC was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Steven Nicoll for inquiries that concern Cellulosic Biotherapeutics LLC by calling the company number (215) 573-8196, as your correspondence is most welcome. Additionally, the physical location of the single location of Cellulosic Biotherapeutics LLC can be found at the coordinates 39.953553,-75.18659 as well as the street address 3160 Chestnut St in Philadelphia, Pennsylvania 19104.
For its online presence, you may visit Cellulosic Biotherapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.